Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21Uterine Cervical Neoplasms 15Esophageal Neoplasms 3Endometrial Neoplasms 3Breast Neoplasms 3Vaginal Neoplasms 2Rhabdomyosarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Melanoma 2Uveal Melanoma 1Uterine Neoplasms 1Sarcoma 1Retinoblastoma 1Recurrent Head and Neck Carcinoma 1Prostatic Diseases 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Gynecologic Cancer 1Esophageal Squamous Cell Carcinoma 1Endometrial Clear Cell Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Cervical Adenocarcinoma 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

Oxaliplatin 19pembrolizumab 13Fluorouracil 12Leucovorin 11Capecitabine 11Paclitaxel 10Gemcitabine 8Docetaxel 8zolbetuximab 6cemiplimab 6Cisplatin 6Albumin-Bound Paclitaxel 6durvalumab 5Ramucirumab 5Radiotherapy 5Irinotecan 4Cyclophosphamide 4130-nm albumin-bound paclitaxel 4trastuzumab deruxtecan 3tislelizumab 3lenvatinib 3enzalutamide 3darolutamide 3Trastuzumab 3Taxes 3S 1 (combination) 3Radiosurgery 3Pemetrexed 3Nivolumab 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Brachytherapy × 1 year × Clear all
NCT07182279 2026-03-09

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

The Methodist Hospital Research Institute

Phase 1/2 Recruiting
29 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡